Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.67
Delayed Data
As of 3:59pm ET
 -0.13 / -2.24%
Today’s Change
4.60
Today|||52-Week Range
11.72
-34.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues7.9M44.4M8.7M69.4M
 
 
 
 
 
Cost of Goods Sold624.0K855.0K----
 
 
 
Depreciation And Amortization939.0K545.0K565.0K2.1M
 
 
 
 
 
 
Operating ExpensesGross Income6.3M43.0M----
 
 
 
General Expenses47.0M42.7M45.4M58.8M
 
 
 
 
 
Research And Development34.1M27.7M28.2M37.6M
 
 
 
 
 
Total Operating Expenses48.6M44.1M46.0M60.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.7M296.0K-37.3M8.5M
 
 
 
 
 
Extraordinary Credit--7.3M0.004.6M
 
 
 
Extraordinary Charge-2.3M-4.2M-2.0M0.00
 
 
 
 
Interest Expense On Debt--0.000.00800.0K
 
 
Other Expenses0.000.000.00-34.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.9M3.4M-39.3M12.6M
 
 
 
 
 
Income Taxes-362.0K-989.0K-133.0K-1.8M
 
 
 
 
 
Minority Interest0.000.00-7.0K-73.0K
 
 
 
Net Income-42.6M4.4M-39.1M10.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.8M68.2M69.7M70.0M
 
 
 
 
 
Shares To Calculate EPS Diluted55.8M68.2M69.7M70.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.76$0.06-$0.56$0.15
 
 
 
 
 
EPS Diluted-$0.76$0.06-$0.56$0.15